Lubner David Charles

CIK 000157200010 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001572000

Recent Transactions

50 trades

Sale
Arcellx, Inc.$ACLX
Common Stock
2026-01-20$75.00/sh−6,000→ 21,659 total
Exercise/Conversion
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-01-20−6,000→ 59,405 total
Exercise/Conversion
Arcellx, Inc.$ACLX
Common Stock
2026-01-20$6.28/sh+6,000→ 27,659 total
Disposition to Issuer
CARGO Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-19−25,000→ 0 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (Right to Buy)
2025-06-23+9,023→ 9,023 total
Award
CARGO Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-18+25,000→ 25,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2025-05-30+35,000→ 35,000 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2025-05-29+9,174→ 9,174 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2025-05-22+30,000→ 30,000 total
Award
CARGO Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-04+23,742→ 23,742 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2024-05-28+8,011→ 8,011 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2024-05-23+30,000→ 30,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-05-22+25,133→ 25,133 total
Disposition to Issuer
POINT Biopharma Global Inc.
Common Stock
2023-12-27−3,600→ 0 total
Disposition to Issuer
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-12-27−25,614→ 0 total
Disposition to Issuer
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-12-27−25,000→ 0 total
Disposition to Issuer
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-12-27−44,749→ 0 total
Disposition from Tender
POINT Biopharma Global Inc.
Common Stock
2023-12-26−35,400→ 3,600 total
Award
CARGO Therapeutics, Inc.
Stock Option (Right to Buy)
2023-11-09+25,000→ 25,000 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2023-06-14+11,459→ 11,459 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-06-01+44,749→ 44,749 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2023-05-26+30,000→ 30,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2023-05-24+24,900→ 24,900 total
Purchase
POINT Biopharma Global Inc.
Common Stock
2022-11-23$6.85/sh+3,600→ 3,600 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2022-07-05+7,222→ 7,222 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2022-06-14+16,911→ 16,911 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2022-06-03+19,596→ 19,596 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2022-06-02+25,614→ 25,614 total
Conversion
Arcellx, Inc.$ACLX
Series C Preferred Stock
2022-02-08−21,659→ 0 total
Conversion
Arcellx, Inc.$ACLX
Common Stock
2022-02-08+21,659→ 21,659 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2022-02-03+61,538→ 61,538 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-10-04+17,245→ 17,245 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-10-04+0→ 0 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2021-07-06+25,000→ 25,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2021-05-26+19,596→ 19,596 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-03-12+17,529→ 17,529 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-03-12+25,000→ 25,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2021-02-05+16,900→ 16,900 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-02-05+58,855→ 58,855 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-09-21−177,872→ 0 total
Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2020-09-21+53,625→ 53,625 total
Purchase
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-08-07$2.81/sh+177,872→ 177,872 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2020-07-31+11,156→ 11,156 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2020-07-31+14,444→ 14,444 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2020-04-02−10,416→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−62,500→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−28,571→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−133,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−112,500→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−92,283→ 0 total

Companies

Recent Filings

Address

C/O ARCELLX, INC. 800 BRIDGE PARKWAY

REDWOOD CITY, CA, 94065

View on SEC.gov